EGFR and melanoma: We assume that NC and NC-CC ingredients (Table S1) that can inhibit malignant melanoma proliferation include medium-chain fatty acids which have been shown to enhance immune responses and induce apoptosis in cancer cells through activation of the EGFR/ERK/AP1 signaling pathway [15].